AgomAb Therapeutics NV ADR Balance Sheet
AgomAb Therapeutics NV ADR's total assets for Q4 2025 were €153.71M, a decrease of -7.20% from the previous quarter. AGMB total liabilities were €22.80M for the fiscal quarter, a 21.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
